ID Your IRD is a program provided by Spark Therapeutics which provides free genetic testing for a specific panel of inherited retinal dystrophies.
This program is undergoing significant change at the end of January. Any test kits submitted prior to January 31 will undergo testing of the established panel of the more common mutations associated with approximately 12 inherited rod-mediated retinal dystrophies. After January 31, they will only be processed as a single gene test for biallelic RPE65 mutation. This is the mutation targeted with their recent gene therapy approval, Luxterna. We will need to see any patients with inherited retinal dystrophies, who are looking for free testing options, immediately. While not comprehensive, this genetic testing panel is the only free option currently available to provide a molecular diagnosis for some of these patients. If you have any questions, please feel free to call or email Dr. Nowakowski. 205-943-4600 or [email protected]
0 Comments
Leave a Reply. |
AuthorThe staff and doctors at VisionAmerica are committed to providing relevant information for you, your patients and your practice. We hope you find the information in our blog post helpful. Archives
August 2019
Categories |